Your session is about to expire
← Back to Search
Holmium laser with thulium lasers for Kidney Stones
Study Summary
This trial will compare the holmium laser with Moses versus the thulium laser in patients undergoing ureteroscopic laser lithotripsy for stone disease.
- Kidney Stones
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has the combination of Holmium and Moses lasers been validated by the Federal Drug Administration?
"The safety of holmium laser with Moses lasers is rated at 3 since it has already been sanctioned as part of a Phase 4 trial."
Who is the ideal candidate for participating in this research?
"This clinical trial seeks 164 participants aged 18 to 89 with kidney stones that require endoscopic treatment in the outpatient operating room. Endorsed applicants must have a single renal unit stone size of 3-10 mm or 11-20 mm, as calculated from preoperative CT scans. Those with multiple stones can still qualify so long as their largest one is within the predetermined range."
What is the participant size of this clinical experiment?
"Affirmative. Clinicaltrials.gov indicates that the trial, which was initially posted on July 16th 2021, is actively recruiting participants. 164 individuals need to be enrolled from 1 facility."
Does this trial accept applicants in their golden years?
"The age bracket for enrollment in this clinical trial is between 18 and 89 years old, as specified by the inclusion criteria."
Is there an ongoing enrollment process for this research project?
"Affirmative. According to the clinicaltrials.gov platform, this trial is actively recruiting individuals who meet its criteria and was first published on July 16th 2021. The current goal is to enroll 164 participants at a single location by August 1st 2022."
Share this study with friends
Copy Link
Messenger